Viewing StudyNCT05681260



Ignite Creation Date: 2024-05-06 @ 6:30 PM
Last Modification Date: 2024-10-26 @ 2:49 PM
Study NCT ID: NCT05681260
Status: RECRUITING
Last Update Posted: 2024-02-12
First Post: 2022-12-27

Brief Title: Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma T-LBL
Sponsor: Childrens Cancer Group China
Organization: Childrens Cancer Group China

Organization Data

Organization: Childrens Cancer Group China
Class: NETWORK
Study ID: CCCG-T-LBL-2023
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Childrens Cancer Group China
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Qilu Childrens Hospital UNKNOWN
Shanghai Childrens Medical Center OTHER
Beijing Childrens Hospital OTHER
Childrens Hospital of Scow University UNKNOWN
West China Second University Hospital OTHER
Nanjing Childrens Hospital OTHER
Qilu Hospital of Shandong University OTHER
Tianjin Medical University Cancer Institute and Hospital OTHER
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science Technology UNKNOWN
Xiangya Hospital of Central South University OTHER
The First Affiliated Hospital of Zhengzhou University OTHER
Cancer hospital of Shandong Province UNKNOWN
Shenzhen Childrens Hospital OTHER_GOV
Wuhan Childrens Hospital OTHER
Zhejiang University School of Medicine Childrens Hospital UNKNOWN
Shanghai Childrens Hospital OTHER
Ruijin Hospital OTHER
Second Affiliated Hospital of Anhui Medical University UNKNOWN
Childrens Hospital of Hebei Province OTHER
Cancer Hospital of Henan Province UNKNOWN
Sun Yat-Sen Memorial Hospital Zhongshan University UNKNOWN